DDX3 has divergent roles in head and neck squamous cell carcinomas in smoking versus non-smoking patients

Oral Diseases

Volumn 21, Issue 2, 2015, Pages 270-271

  Heerma van Voss, M R ^a,b   van Kempen, P M W ^b   Noorlag, R ^b   van Diest, P J ^b   Willems, S M ^b   Raman, V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Head and neck oral cancers; Infections and the aetiology of cancer; Molecular markers of metastasis and progression; Tobacco

Indexed keywords

CIGARETTE SMOKE; DDX3 PROTEIN; DIHYDROXYBENZO[A]PYRENE OXIDE; PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; DEAD BOX PROTEIN;

BREAST CELL; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMICAL CARCINOGENESIS; CYTOPLASM; FRAMESHIFT MUTATION; GENE DELETION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; LETTER; MALIGNANT TRANSFORMATION; MEDULLOBLASTOMA; MOUTH SQUAMOUS CELL CARCINOMA; NON SMALL CELL LUNG CANCER; NONSENSE MUTATION; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SMOKING; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TRANSFORMED CELL; UPREGULATION; WART VIRUS; FEMALE; GENETICS; MALE; MOUTH TUMOR;

CARCINOMA, SQUAMOUS CELL; DEAD-BOX RNA HELICASES; FEMALE; HUMANS; MALE; MOUTH NEOPLASMS;

EID: 84923009703     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12299     Document Type: Letter

References (11)

1. Angus AG, Dalrymple D, Boulant S et al (2010). Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J Gen Virol 91: 122-132.
2. Botlagunta M, Vesuna F, Mironchik Y et al (2008). Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 27: 3912-3922.
3. India Project Team of the International Cancer Genome Consortium (2013). Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun 4: 2873.
4. Ko C, Lee S, Windisch MP, Ryu WS (2014). DDX3 DEAD-Box RNA helicase is a host factor that restricts hepatitis b virus replication at the transcriptional level. J Virol 88: 13689-13698.
5. Lee CH, Lin SH, Yang SF et al (2014). Low/negative expression of DDX3 might predict poor prognosis in non-smoker patients with oral cancer. Oral Dis 20: 76-83.
6. Oshiumi H, Sakai K, Matsumoto M, Seya T (2010). DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur J Immunol 40: 940-948.
7. Pugh TJ, Weeraratne SD, Archer TC et al (2012). Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488: 106-110.
8. Seiwert TY, Zuo Z, Keck MK et al (2014). Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res [published online ahead of print 2014 Jul 23] DOI:10.1158/1078-0432.CCR-13-3310.
9. Stransky N, Egloff AM, Tward AD et al (2011). The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
10. Wu DW, Liu WS, Wang J, Chen CY, Cheng YW, Lee H (2011). Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer. Clin Cancer Res 17: 1895-1905.
11. Yedavalli VS, Neuveut C, Chi YH, Kleiman L, Jeang KT (2004). Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119: 381-392.